AI-Designed Drugs by a DeepMind Spinoff Are Headed to Human Trials
Published: (April 24, 2026 at 01:17 PM EDT)
1 min read
Source: Wired
Source: Wired
Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting pipeline of new medicines.”